<table id="table_3" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_af06d51c-154b-4ba8-95ba-57678f100891">Table 3: Active Metabolite Pharmacokinetics and Antiplatelet Responses by CYP2C19 Metabolizer Status</caption>
<col align="left" width="25%"></col>
<col align="left" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<thead>
<tr id="id_b5cc84ed-3ecd-40e0-8c62-cba89af9d021" stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top">Dose</td>
<td align="left" stylecode="Rrule" valign="top">Ultrarapid <br/>(n=10)</td>
<td align="left" stylecode="Rrule" valign="top">Extensive <br/>(n=10)</td>
<td align="left" stylecode="Rrule" valign="top">Intermediate <br/>(n=10)</td>
<td align="left" stylecode="Rrule" valign="top">Poor <br/>(n=10)</td>
</tr>
</thead>
<tfoot id="id_2f9d32d0-e40f-4795-b92b-4a1f1af70df9">
<tr>
<td align="left" colspan="6" stylecode="Lrule Rrule" valign="top">Values are mean (SD)</td>
</tr>
</tfoot>
<tbody>
<tr id="id_d39f74fc-48c4-493c-9c77-7c99593a5a2c" stylecode="Toprule">
<td align="left" stylecode="Lrule" valign="top">Cmax (ng/mL)</td>
<td align="left" stylecode="Toprule" valign="top">300 mg (24 h)</td>
<td align="left" stylecode="Toprule" valign="top">24 (10)</td>
<td align="left" stylecode="Toprule" valign="top">32 (21)</td>
<td align="left" stylecode="Toprule" valign="top">23 (11)</td>
<td align="left" stylecode="Rrule" valign="top">11 (4)</td>
</tr>
<tr id="id_621e7c52-8f99-4be7-9e89-b683c3cc494f">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">600 mg (24 h)</td>
<td align="left" valign="top">36 (13)</td>
<td align="left" valign="top">44 (27)</td>
<td align="left" valign="top">39 (23)</td>
<td align="left" stylecode="Rrule" valign="top">17 (6)</td>
</tr>
<tr id="id_fb0ed7f4-343b-4361-b9c0-2d07a985ec42">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">75 mg (Day 5)</td>
<td align="left" valign="top">12 (6)</td>
<td align="left" valign="top">13 (7)</td>
<td align="left" valign="top">12 (5)</td>
<td align="left" stylecode="Rrule" valign="top">4 (1)</td>
</tr>
<tr id="id_c2df06fb-f2b9-4156-9f0e-8abd545297f2">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">150 mg (Day 5)</td>
<td align="left" valign="top">16 (9)</td>
<td align="left" valign="top">19 (5)</td>
<td align="left" valign="top">18 (7)</td>
<td align="left" stylecode="Rrule" valign="top">7 (2)</td>
</tr>
<tr id="id_6eaf7638-64e6-4402-b053-799a7d4935a1">
<td align="left" stylecode="Lrule" valign="top">IPA (%)<footnote id="idapor4g">Inhibition of platelet aggregation with 5µM ADP; larger value indicates greater platelet inhibition</footnote>
</td>
<td align="left" valign="top">300 mg (24 h)</td>
<td align="left" valign="top">40 (21)</td>
<td align="left" valign="top">39 (28)</td>
<td align="left" valign="top">37 (21)</td>
<td align="left" stylecode="Rrule" valign="top">24 (26)</td>
</tr>
<tr id="id_049688cc-f14e-495d-96f8-174dc9c40c21">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">600 mg (24 h)</td>
<td align="left" valign="top">51 (28)</td>
<td align="left" valign="top">49 (23)</td>
<td align="left" valign="top">56 (22)</td>
<td align="left" stylecode="Rrule" valign="top">32 (25)</td>
</tr>
<tr id="id_b8d3600e-bba2-4d23-bcd0-c70ab5a3c42b">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">75 mg (Day 5)</td>
<td align="left" valign="top">56 (13)</td>
<td align="left" valign="top">58 (19)</td>
<td align="left" valign="top">60 (18)</td>
<td align="left" stylecode="Rrule" valign="top">37 (23)</td>
</tr>
<tr id="id_20818b61-465b-4f1a-b0ee-be51e232a8ee">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">150 mg (Day 5)</td>
<td align="left" valign="top">68 (18)</td>
<td align="left" valign="top">73 (9)</td>
<td align="left" valign="top">74 (14)</td>
<td align="left" stylecode="Rrule" valign="top">61 (14)</td>
</tr>
<tr id="id_461249d0-fe6c-4b67-b906-932fcbcb5958">
<td align="left" stylecode="Lrule" valign="top">VASP-PRI (%) <footnote id="idazqr4g">Vasodilator-stimulated phosphoprotein – platelet reactivity index; smaller value indicates greater platelet inhibition</footnote>
</td>
<td align="left" valign="top">300 mg (24 h)</td>
<td align="left" valign="top">73 (12)</td>
<td align="left" valign="top">68 (16)</td>
<td align="left" valign="top">77 (12)</td>
<td align="left" stylecode="Rrule" valign="top">91 (12)</td>
</tr>
<tr id="id_3bed9741-5408-4aeb-94bd-6581b841d6ce">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">600 mg (24 h)</td>
<td align="left" valign="top">51 (20)</td>
<td align="left" valign="top">48 (20)</td>
<td align="left" valign="top">56 (26)</td>
<td align="left" stylecode="Rrule" valign="top">85 (14)</td>
</tr>
<tr id="id_edc2ee10-e0a3-4546-973a-474f07849268">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">75 mg (Day 5)</td>
<td align="left" valign="top">40 (9)</td>
<td align="left" valign="top">39 (14)</td>
<td align="left" valign="top">50 (16)</td>
<td align="left" stylecode="Rrule" valign="top">83 (13)</td>
</tr>
<tr id="id_ca1a8b17-64c6-4853-9f4c-2c92f98414c3">
<td align="left" stylecode="Lrule" valign="top"></td>
<td align="left" valign="top">150 mg (Day 5)</td>
<td align="left" valign="top">20 (10)</td>
<td align="left" valign="top">24 (10)</td>
<td align="left" valign="top">29 (11)</td>
<td align="left" stylecode="Rrule" valign="top">61 (18)</td>
</tr>
</tbody>
</table>